GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S.
Posts Tagged ‘Elan Plc (ELN)’
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for a treat this week with...
J.C. Penney Company, Inc. (JCP), Perrigo Company (PRGO), Cabot Oil & Gas Corporation (COG): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Elan Corporation, plc (ADR) (ELN), Tibco Software Inc. (TIBX): What This 758% Gainer Has Been Buying
Today, let's look at investing giant Daniel Loeb, founder of the Third Point LLC hedge fund.
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN), Johnson & Johnson (JNJ): Is This Health Care Stock Underrated?
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
Micron Technology, Inc. (MU), Theravance Inc (THRX): Here’s What Superinvestor Seth Klarman Has Been Buying
Today let's look at investing giant Seth Klarman, who founded the Baupost Group hedge fund company back in 1982. Klarman is a successful investor with a lot to teach us.
Kodiak Oil & Gas Corp (USA) (KOG), Elan Corporation, plc (ADR) (ELN): Here’s What Billionaire John Paulson Has Been Buying
Today, let's look at investing giant John Paulson. Founded in 1994 and owned by its employees, Paulson & Co.
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): This Deal Could Shake Up the Generic Drug Business
Many market-watchers are scratching their heads about the pharmaceutical industry's latest blockbuster deal.
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): Will This Be the Next Irish Biotech Acquisition?
Perrigo Company (NYSE:PRGO)’s acquisition of Elan Corporation, plc (ADR) (NYSE:ELN) for $8.6 billion has been widely criticized by many as a way for Perrigo to avoid paying...
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): This Merger Adds Value Multiple Ways
2013 is turning out to be a stellar year for Mergers and Acquisitions. There have been a number of M&A deals in healthcare and technology sectors.
Dell Inc. (DELL), Elan Corporation, plc (ADR) (ELN): You’re a Bad Investor. Here’s How to Get Better.
The chances are good that you're a bad investor.
Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): Is This Acquisition a Game Changer?
A patented drug is a cash cow for drug manufacturers. There are two ways to have a patented cash generating drug on a pharmaceutical company’s pipeline.
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Strange Biotech Bedfellows
When I interviewed Alkermes Plc (NASDAQ:ALKS)' CEO Richard Pops last year, he described the relocation of the company's headquarters to Ireland where taxes are lower after buying...
Perrigo Company (PRGO) to Buy Elan Corporation, plc (ADR) (ELN) for $8.6 Billion
After months of fighting off the advances of unwanted suitor Royalty Pharma, Irish biotech Elan Corporation, plc (ADR) (NYSE:ELN) finally got an offer it couldn't refuse -- from...
Elan Corporation, plc (ADR) (ELN): The Biggest Insider Trade in History
By now you've probably at least heard of SAC Capital, the massive hedge fund founded and run by the eponymous Steven A. Cohen.
What’s Next for Elan Corporation, plc (ADR) (ELN)?
Elan Corporation, plc (ADR) (NYSE:ELN)'s board unanimously rebuffed a $6.7 billion takeover offer from Royalty Pharma in early June and hired Citigroup Inc.
Valeant Pharmaceuticals Intl Inc (VRX), Hospira, Inc. (HSP), Elan Corporation, plc (ADR) (ELN): 3 Pharma Companies to Buy for the Long Run
According to IMS health report, the global pharmaceutical industry is expected to grow at a CAGR of 4.5% in the next five years to reach $1.20 trillion in 2017, from $963 billion...
Elan Corporation, plc (ADR) (ELN), VIVUS, Inc. (VVUS), MannKind Corporation (MNKD): Three Biotech Companies to Watch This Summer
The news flow from biotech companies might slow down during the summer, but it won't stop.
Is Elan Corporation, plc (ADR) (ELN) Pushing Its Luck?
Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow...
Biogen Idec Inc. (BIIB): Elan Corporation, plc (ADR) (ELN) Likely To Receive Higher Takeout Bids
Elan Corporation, plc (ADR) (NYSE:ELN) has been in the news over the past few months because of a hotly contested battle with Royalty Pharma. The battle began on Feb.
Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks
It's understandably very tempting for people with inside information to trade biotech stocks.
Dynavax Technologies Corporation (DVAX), Elan Corporation, plc (ADR) (ELN): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK): Another Alzheimer’s Disease Failure
The latest drug to bite the dust is LY2886721, a beta secretase, or BACE, inhibitor.
BP plc (ADR) (BP), Oracle Corporation (ORCL): Value Investor Seth Klarman’s Shakeups
Seth Klarman's Baupost Group, led by the famed value investor and author of Margin of Safety, recently revealed its public equity portfolio in its quarterly filing with the SEC...
GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc (THRX): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation, plc (ADR) (ELN): Who Benefits From This Market Moving Biotechnology Partnership?
Back towards the end of April 2013, Theravance Inc (NASDAQ:THRX) surprised everyone when it announced plans to split into two separate companies.
Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY), Elan Corporation, plc (ADR) (ELN): The Greatest Thing Since Sliced Bread Has Arrived for MS Patients
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a financial and quality of ...
Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Decision Looms on New Multiple Sclerosis Drug
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so.
Better Biotech Buy: Biogen Idec Inc. (BIIB) vs. Celgene Corporation (CELG)
Buying big pharma stocks isn't the only way you can invest in today's best-selling drugs without taking a gamble on a small, risky biotech.
Will Eli Lilly & Co. (LLY) Help You Retire Rich? – GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ)
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
The Fight Over This Biotech’s Cash: Elan Corporation, plc (ADR) (ELN)
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen...
Elan Corporation, plc (ADR) (ELN) Received Buyout Bid Before Buyback
When Elan Corporation, plc (ADR) (NYSE:ELN) sold its stake in the blockbuster selling multiple sclerosis drug Tysabri to partner Biogen Idec Inc.
BioMarin Pharmaceutical Inc. (BMRN) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Has Avanir Pharmaceuticals, Inc. (AVNR) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Why Elan Corporation, plc (ELN) Cut Its Ties To Tysabri
Elan Corporation, plc (NYSE:ELN) just announced a restructuring of its Tysabri collaboration with Biogen Idec Inc.
Has Elan Corporation, plc (ADR) (ELN) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
A Win-Win Multiple Sclerosis Deal? – Biogen Idec Inc. (BIIB), Elan Corporation, plc (ELN)
Biogen Idec Inc. (NASDAQ:BIIB) is buying the full rights to multiple sclerosis drug Tysabri from Elan Corporation, plc (ADR) (NYSE:ELN) for $3.25 billion.
Hedge Fund Resource Center
